Oxohexyl methylxanthine compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514885, 514886, A61K 3152

Patent

active

057958971

ABSTRACT:
There is disclosed a pharmaceutical composition comprising 1-(5-oxohexyl)-3-methylxanthine in admixture with a pharmaceutically acceptable excipient, wherein the pharmaceutical composition is useful for treating an immune disorder. There is also disclosed a method to modulate the response of a target cell to a stimulus, which method comprises contacting said cell with an amount of 1-(5-oxohexyl)-3-methylxanthine or a pharmaceutical composition thereof, wherein said amount effects a diminution in elevated levels of unsaturated, non-arachidonate phosphatidic acid (PA) and diacylglycerol (DAG) derived from said PA in said cells wherein said elevated levels are stimulated by an agent capable of elevating levels of said PA and said DAG, said diminution being equal to or greater than the diminution effected by treating said cells with pentoxifylline (PTX) at a concentration of 0.5 mmol, thereby modulating the response of said target cell.

REFERENCES:
patent: 3422107 (1969-01-01), Mohler et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 4975432 (1990-12-01), Weithmann
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5118500 (1992-06-01), Hanel et al.
patent: 5288721 (1994-02-01), Klein et al.
patent: 5652243 (1997-07-01), Bianco et al.
patent: B13373737 (1987-03-01), Mohler et al.
Davis et al., Applied Environment. Microbiol. 48:327, 1984.
Bianco et al., Blood 78:1205, 1991.
Singer et al., "Effect of Methylxanthine Derivatives on T cell Activation" Bone Marrow Transplantation 10:19, 1992.
Chemical Abstracts An 88-127584 (Dethlefsen et al., May 11, 1988).
J.Pharm. Pharmacol; vol. 44 (11), Issued Nov. 1992, Miyamoto et al, "Selective Bronchodilators from 1-(5'-Oxohexyl)xanthines", pp. 888-892.
Chemical Abstracts 1988: 105950, Wijnandy et al., 1988.
Chemical Abstracts 88-127584, issued 1989, corresponding to DE 3637241 to Dethlefson et al., "Pharmaceutical Compsns. Contg. Nifedipine -and complexing Substance to increase water-solubility", (Abstract only).
Medline Abstract # 88256298 Sullivan et al, "Inhibition of the Inflammatory Action of interleukin-1 and Tumor Necrosis Factor on neutrophil Function by Pentoxifylline", Infect Immun, 56(7)1722-9, Jul. 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oxohexyl methylxanthine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxohexyl methylxanthine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxohexyl methylxanthine compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1115028

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.